Cargando…

Efficacy and safety of concurrent chemoradiotherapy with or without Nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and neck: Prospective comparative study - ESCORT-N study

BACKGROUND: Nimotuzumab is an anti-epidermal growth factor receptor monoclonal antibody which can be added to chemoradiotherapy (CRT) to improve efficacy for management of locally advanced squamous cell carcinoma of the head and neck (LASCCHN). We prospectively evaluated the efficacy and safety of n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Ashok, Chakravarty, Nilotpal, Bhatnagar, Sharad, Chowdhary, G. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	ORIGINAL ARTICLE: Head and Neck Cancers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498712/ https://www.ncbi.nlm.nih.gov/pubmed/31069191 http://dx.doi.org/10.4103/sajc.sajc_38_18

Ejemplares similares

Safety and efficacy of nimotuzumab with concurrent chemoradiotherapy in unresectable locally advanced squamous cell carcinoma of head and neck: An Indian rural hospital experience
por: Rawat, Shyamji, et al.
Publicado: (2019)

Efficacy and safety of nimotuzumab in unresectable, recurrent, and/or metastatic squamous cell carcinoma of the head and neck: A hospital-based retrospective evidence
por: Subramanian, Sundaram, et al.
Publicado: (2018)

Nimotuzumab with intensity-modulated radiation therapy in unresectable and platinum-ineligible locally advanced head-and-neck cancer
por: Srinivas, K. Satish, et al.
Publicado: (2020)

Effectiveness and tolerability of nimotuzumab in unresectable, locally advanced/metastatic esophageal cancer: Indian hospital-based retrospective evidence
por: Subramanian, Sundaram, et al.
Publicado: (2019)

The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma
por: Wilson, Harper L., et al.
Publicado: (2020)

Microvessel density in head and neck squamous cell carcinoma
por: Szafarowski, Tomasz, et al.
Publicado: (2018)

Body composition analysis in head and neck squamous cell carcinoma
por: Malecka-Massalska, Teresa, et al.
Publicado: (2013)

Treatment of Oligometastatic Disease in Squamous Cell Carcinoma of the Head and Neck
por: Vincent, Aurora G., et al.
Publicado: (2020)

Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands
por: van der Linden, Naomi, et al.
Publicado: (2015)

Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial
por: Curry, Joseph, et al.
Publicado: (2017)

Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures
por: Mes, Steven W., et al.
Publicado: (2020)

Causes of long-term mortality in patients with head and neck squamous cell carcinomas
por: Lop, Joan, et al.
Publicado: (2021)

The role of elective neck dissection in T1 and T2 nasal cavity squamous cell carcinomas
por: Lill, Claudia, et al.
Publicado: (2022)

Outcomes following oropharyngeal squamous cell carcinoma resection and bilateral neck dissection with or without contralateral postoperative radiotherapy of the pathologically node-negative neck
por: Jansen, Florian, et al.
Publicado: (2023)

Sentinel lymph node biopsy in squamous cell carcinoma of the head and neck: 10 years of experience
por: ANTONIO, J.K., et al.
Publicado: (2012)

Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma
por: Szewczyk, Mateusz, et al.
Publicado: (2014)

SEC61G identified as a prognostic biomarker of head and neck squamous cell carcinoma
por: Shi, Yanan, et al.
Publicado: (2021)

Inhibition of beta-catenin shows therapeutic potential in head and neck squamous cell carcinoma in vitro
por: Maier, Tobias, et al.
Publicado: (2022)

Choice of psychological coping in laryngectomized, head and neck squamous cell carcinoma patients versus multiple sclerosis patients
por: Aarstad, A. K. H., et al.
Publicado: (2010)

N3 (> 6 cm) squamous cell carcinoma of the head and neck: outcomes and predictive factors in 104 patients
por: Sellami, Selima, et al.
Publicado: (2021)

The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation
por: Rühle, Alexander, et al.
Publicado: (2023)

Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases
por: Grammatica, Alberto, et al.
Publicado: (2021)

Acupuncture for radiation-induced toxicity in head and neck squamous cell carcinoma: a systematic review based on PICO criteria
por: Bonomo, Pierluigi, et al.
Publicado: (2021)

Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy
por: León, Xavier, et al.
Publicado: (2022)

Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma
por: Bianchini, Chiara, et al.
Publicado: (2023)

Quantitative clinical outcomes of therapy for head and neck lymphedema
por: Doke, Kaleigh N., et al.
Publicado: (2018)

Combined chemoradiotherapy with local microwave hyperthermia for treatment of T3N0 laryngeal carcinoma: a retrospective study with long-term follow-up
por: KOULOULIAS, V., et al.
Publicado: (2014)

Extracranial head and neck schwannomas: a study of the nerve of origin
por: Liu, Hin-Lun, et al.
Publicado: (2011)

Head and neck cancer. An aetiopathogenetic study of non-endemic lymphoepithelioma
por: CASCO, F.G., et al.
Publicado: (2013)

Diagnostic accuracy of combined optical- and radio-guided SNB for neck staging of oral squamous cell carcinoma lesions in the anterior oral cavity
por: Christensen, Anders, et al.
Publicado: (2023)

The prognostic-nutritional index in HPV-negative head and neck squamous cell carcinoma treated with upfront surgery: a multi-institutional series
por: Tomasoni, Michele, et al.
Publicado: (2023)

A decision analysis model for elective neck dissection in patients with cT1-2 cN0 oral squamous cell carcinoma
por: KÖHLER, H.F., et al.
Publicado: (2019)

Multiparametric functional MRI and (18)F-FDG-PET for survival prediction in patients with head and neck squamous cell carcinoma treated with (chemo)radiation
por: Martens, Roland M., et al.
Publicado: (2020)

Premature discontinuation of curative radiation therapy: Insights from head and neck irradiation
por: Lazarev, Stanislav, et al.
Publicado: (2017)

Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences
por: Becker, Minerva, et al.
Publicado: (2017)

Does 5 + 5 Equal Better Radiation Treatment Plans in Head and Neck Cancers?
por: Corkum, Mark T., et al.
Publicado: (2019)

Quality of life, cognitive, physical and emotional function at diagnosis predicts head and neck cancer survival: analysis of cases from the Head and Neck 5000 study
por: Rogers, S. N., et al.
Publicado: (2020)

Psychological distress and nutritional status in head and neck cancer patients: a pilot study
por: Gosak, Maja, et al.
Publicado: (2020)

A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
por: Balk, Matthias, et al.
Publicado: (2023)

Morphological MRI criteria improve the detection of lymph node metastases in head and neck squamous cell carcinoma: multivariate logistic regression analysis of MRI features of cervical lymph nodes
por: de Bondt, R. B. J., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_gjdp7fga6hl3tqt9op1c2k01es